Ironwood Investment Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Sell
44,435
-3,272
-7% -$10.4K 0.04% 176
2025
Q4
$191K Sell
47,707
-2,390
-5% -$13.3K 0.08% 161
2025
Q3
$424K Sell
50,097
-389
-0.8% -$3.77K 0.18% 120
2025
Q2
$568K Buy
50,486
+3,857
+8% +$35.4K 0.28% 101
2025
Q1
$442K Sell
46,629
-5,443
-10% -$55K 0.24% 104
2024
Q4
$586K Buy
52,072
+27,927
+116% +$491K 0.29% 93
2024
Q3
$683K Buy
+24,145
New +$622K 0.33% 86

Other funds holding EVH

Ironwood Investment Management's EVH Position: Q1 2026 in Review

Ironwood Investment Management reduced its Evolent Health (EVH) stake by 6.9% in Q1 2026, selling an estimated $10.4K and leaving 44,435 shares worth $101K. The position accounts for 0.04% of the portfolio, ranked #176.

Ironwood Investment Management first reported a position in EVH in Q3 2024 and has held it in 7 quarters since. The position peaked at $683K in Q3 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Ironwood Investment Management held 44,435 shares of Evolent Health worth $101K as of Q1 2026.
  • Ironwood Investment Management sold 3,272 Evolent Health shares in Q1 2026, an estimated $10.4K.
  • Evolent Health made up 0.04% of Ironwood Investment Management's portfolio in Q1 2026, its #176 holding.
  • Ironwood Investment Management first reported a position in Evolent Health in Q3 2024 and has held it in 7 quarters since.
  • Ironwood Investment Management's Evolent Health position peaked at $683K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.